Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 430.59 Million | USD 736.79 Million | 6.15% | 2023 |
The global UV infection control device (ICD) market size was worth around USD 430.59 million in 2023 and is predicted to grow to around USD 736.79 million by 2032 with a compound annual growth rate (CAGR) of roughly 6.15% between 2024 and 2032.
UV infection control devices (ICDs) are systems and equipment that are utilized to sterilize, sanitize, and disinfect various products, tools, and others using UV light. Generally, UV infection control devices (ICDs) are utilized to sanitize water, wastewater, air, process water, and surfaces, among others. When bacteria, viruses, and protozoa are exposed to a range of 200 and 300 nanometer wavelengths of UV light, they are rendered incapable of reproducing and infecting. UV light can be effective against pathogenic organisms such as cholera, polio, typhoid, hepatitis, and other bacterial, viral, and parasitic diseases. UV infection control devices (ICDs) are available as stationary and mobile devices.
The major factors driving the growth of the UV infection control device (ICD) market are the Millennium Development Goals (MDGs) and Sustainable Development Goals (SDGs) of the UN for water treatment and clean water. World Health Organization (WHO) estimated that around 7 million deaths occur annually due to various infections that spread through water, air, and surfaces. These deaths can be prevented with proper disinfection and sanitization techniques. Sustainable Development Goals (SDGs) by the UN which would strive to achieve 17 goals by 2032 have “clean water and sanitation for all” as one of its prime goals.
Increasing needs for safe drinking water in developing regions have further boosted the demand for UV ICDs. Around 663 million people across the globe don’t have access to clean drinking water. Thus, this factor is expected to boost the demand for UV ICDs during the forecast period.
Currently, numerous disinfectants and curing chemicals are widely used for sterilization purposes. These chemicals pose grave threats to the environment as well as lead to residue after its usage. These factors could propel the replacement of harmful disinfectants and curing chemicals with UV ICDs.
However, comparatively lower costs of conventional disinfectant products coupled with the inability of UV ICDs to treat residuals could hamper the adoption and growth of UV ICDs during the forecast period.
Mobile-type UV ICDs are versatile and can be moved and transported to different locations with relative ease. This versatility and mobility have boosted the demand for mobile type UV ICDs. The stationary-type UV ICDs are fixed to one location or spot and cannot be moved or transported. Stationary type UV ICDs are expected to grow at a CAGR of 16.5% from 2024 to 2032. Mobile type UV ICDs are expected to generate revenues of more than USD 3750.23 million by 2032.
Hospitals dominate the global UV infection control device market. Most hospitals employ some type of UV ICDs on their premises. UV ICDs are used in the operation rooms, equipment room, and patient room, and can also be used in the duct, surface, and mobile rooms among others in hospitals. Hospital-acquired infections (HAI) and drug-resistant bacteria could be sterilized and prevented with the aid of UV ICDs. Thus, hospitals have a huge demand for UV ICDs. Hospitals contributed to around 48.15% share of the total demand for UV ICDs in 2023.
Water, wastewater & process water treatment applications contributed to more than USD 1,600.23 million in 2023. UV ICDs assist in treating water, wastewater, and processed water from industries. Treatment by UV ICDs does not leave any by-products in the treated water and is comparatively cheaper and easily available as compared to other water treatment technologies. Surface disinfection application is expected to grow at a leading CAGR of more than 24.33% during the forecast period.
Report Attributes | Report Details |
---|---|
Report Name | UV Infection Control Device (ICD) Market |
Market Size in 2023 | USD 430.59 Million |
Market Forecast in 2032 | USD 736.79 Million |
Growth Rate | CAGR of 6.15% |
Number of Pages | 210 |
Key Companies Covered | 3M, American Air & Water, Inc., American Ultraviolet, Inc., AquiSense Technologies, Atlantic Ultraviolet Corporation, Diversey, Inc., First Light Technologies, Inc., Getinge Group, Skytron LLC (Infection Prevention Technologies), KLM Medical Equipment, Koninklijke Philips N.V., Lumalier Corporation, Seal Shield LLC, STERIS Plc., The Clorox Company, UVC Cleaning Systems, Xenex Disinfection Services, Xylem Inc., Tru-D Smart UVC, Ultraviolet Devices, Inc., and others. |
Segments Covered | By Type, By End-User, By Application, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
UV Infection Control Device Market: Regional Analysis
The major market share for the UV infection control device market was contributed by North America. North America dominates the global UV infection control device market. The presence of a high number of hospitals, clinics & laboratories, pharmaceutical companies, and water and wastewater treatment facilities has boosted the demand for UV ICD solutions in this region. In addition, stringent regulations regarding sterilization and disinfection of water and limitations on the use of disinfectant chemicals have led to the adoption of UV ICD solutions in this region.
The global UV infection control device (ICD) market is dominated by players like:
The prominent market players maintain a competitive edge in the global market by injecting higher investments in R&D activities. The introduction of innovative products and technologies further strengthens the market position of companies. Furthermore, merger and acquisition activities have assisted companies to improve their product portfolio as well as expand global presence to capture new markets. AquiSense Technologies and Distform S.L. collaborated to offer award-winning “Food Protection” solutions. Similarly, Skytron acquired Infection Prevention Technologies (IPT) assets and their patented technologies such as IPT UV Disinfection Technology.
The global UV infection control device market is segmented as follows:
By Type
By End-User Type
By Application
By Region
FrequentlyAsked Questions
The UV infection control device is a disinfection technology that utilizes Ultraviolet radiation to eradicate bacteria in different healthcare institutions such as hospitals, clinics, ambulatory surgical centers, research facilities, emergency departments, and others.
According to a study, the global UV infection control device (ICD) market size was worth around USD 430.59 million in 2023 and is expected to reach USD 736.79 million by 2032.
The global UV infection control device (ICD) market is expected to grow at a CAGR of 6.15% during the forecast period.
North America is expected to dominate the UV infection control device (ICD) market over the forecast period.
Leading players in the global UV infection control device (ICD) market include 3M, American Air & Water, Inc., American Ultraviolet, Inc., AquiSense Technologies, Atlantic Ultraviolet Corporation, Diversey, Inc., First Light Technologies, Inc., Getinge Group, Skytron LLC (Infection Prevention Technologies), KLM Medical Equipment, Koninklijke Philips N.V., Lumalier Corporation, Seal Shield LLC, STERIS Plc., The Clorox Company, UVC Cleaning Systems, Xenex Disinfection Services, Xylem Inc., Tru-D Smart UVC, and Ultraviolet Devices, Inc., among others.
The UV infection control device (ICD) market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed